107 related articles for article (PubMed ID: 21800506)
1. Distinct synergistic action of piperacillin and methylglyoxal against Pseudomonas aeruginosa.
Mukherjee S; Chaki S; Das S; Sen S; Dutta SK; Dastidar SG
Indian J Exp Biol; 2011 Jul; 49(7):547-51. PubMed ID: 21800506
[TBL] [Abstract][Full Text] [Related]
2. In vitro synergistic effect of ciprofloxacin with aminoglycosides against multidrug resistant-Pseudomonas aeruginosa.
Yasmin F; Akhtar N; Hameed A
Pak J Pharm Sci; 2013 Sep; 26(5):1041-4. PubMed ID: 24035966
[TBL] [Abstract][Full Text] [Related]
3. In vitro susceptibility pattern of cephalosporin-resistant Gram-negative bacteria.
Punpanich W; Tantichattanon W; Wongwatcharapaiboon S; Treeratweeraphong V
J Med Assoc Thai; 2008 Oct; 91 Suppl 3():S21-7. PubMed ID: 19255989
[TBL] [Abstract][Full Text] [Related]
4. In vitro effects of combinations of antipseudomonal agents against seven strains of multidrug-resistant Pseudomonas aeruginosa.
Oie S; Uematsu T; Sawa A; Mizuno H; Tomita M; Ishida S; Okano Y; Kamiya A
J Antimicrob Chemother; 2003 Dec; 52(6):911-4. PubMed ID: 14585851
[TBL] [Abstract][Full Text] [Related]
5. In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units.
Timurkaynak F; Can F; Azap OK; Demirbilek M; Arslan H; Karaman SO
Int J Antimicrob Agents; 2006 Mar; 27(3):224-8. PubMed ID: 16464562
[TBL] [Abstract][Full Text] [Related]
6. In vitro activities of antibiotic combinations against clincal isolates of Pseudomonas aeruginosa.
Chen YH; Peng CF; Lu PL; Tsai JJ; Chen TP
Kaohsiung J Med Sci; 2004 Jun; 20(6):261-7. PubMed ID: 15253466
[TBL] [Abstract][Full Text] [Related]
7. Study of in vitro antibacterial activity of 19 antimicrobial agents against Pseudomonas aeruginosa.
Wang R; Sun XD; Cai QM
Chin Med J (Engl); 1989 Apr; 102(4):313-8. PubMed ID: 2507247
[TBL] [Abstract][Full Text] [Related]
8. In vitro selection of resistance in Pseudomonas aeruginosa and Acinetobacter spp. by levofloxacin and ciprofloxacin alone and in combination with beta-lactams and amikacin.
Drago L; De Vecchi E; Nicola L; Tocalli L; Gismondo MR
J Antimicrob Chemother; 2005 Aug; 56(2):353-9. PubMed ID: 15967767
[TBL] [Abstract][Full Text] [Related]
9. [Evaluation of synergistic enhancement of antimicrobial activities of piperacillin and amikacin against Pseudomonas aeruginosa using FIC index and disc diffusion method].
Uete T; Matsuo K
Jpn J Antibiot; 1990 Sep; 43(9):1572-8. PubMed ID: 2124633
[TBL] [Abstract][Full Text] [Related]
10. Development of antibiotic resistance in Pseudomonas aeruginosa during two decades of antipseudomonal treatment at the Danish CF Center.
Ciofu O; Giwercman B; Pedersen SS; Høiby N
APMIS; 1994 Sep; 102(9):674-80. PubMed ID: 7946270
[TBL] [Abstract][Full Text] [Related]
11. [Four years of monitoring of antibiotic sensitivity rates of Pseudomonas aeruginosa and Acinetobacter baumannii strains isolated from patients in intensive care unit and inpatient clinics].
Alişkan H; Colakoğlu S; Turunç T; Demiroğlu YZ; Erdoğan F; Akin S; Arslan H
Mikrobiyol Bul; 2008 Apr; 42(2):321-9. PubMed ID: 18697430
[TBL] [Abstract][Full Text] [Related]
12. Use of in vitro critical inhibitory concentration, a novel approach to predict in vivo synergistic bactericidal effect of combined amikacin and piperacillin against Pseudomonas aeruginosa in a systemic rat infection model.
Chan E; Zhou S; Srikumar S; Duan W
Pharm Res; 2006 Apr; 23(4):729-41. PubMed ID: 16554956
[TBL] [Abstract][Full Text] [Related]
13. Potential synergy activity of the novel ceragenin, CSA-13, against clinical isolates of Pseudomonas aeruginosa, including multidrug-resistant P. aeruginosa.
Chin JN; Jones RN; Sader HS; Savage PB; Rybak MJ
J Antimicrob Chemother; 2008 Feb; 61(2):365-70. PubMed ID: 18079128
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of ciprofloxacin's synergism with other agents by multiple in vitro methods.
Moody JA; Gerding DN; Peterson LR
Am J Med; 1987 Apr; 82(4A):44-54. PubMed ID: 3107380
[TBL] [Abstract][Full Text] [Related]
15. Role of ciprofloxacin in its synergistic effect with fosfomycin on drug-resistant strains of Pseudomonas aeruginosa.
Yamada S; Hyo Y; Ohmori S; Ohuchi M
Chemotherapy; 2007; 53(3):202-9. PubMed ID: 17356268
[TBL] [Abstract][Full Text] [Related]
16. Comparative in vitro activity of aztreonam, other beta-lactam antibiotics and aminoglycosides against Pseudomonas aeruginosa.
Venditti M; Brandimarte C; Santini C; Valente B; Martino P; Serra P
Chemioterapia; 1984 Aug; 3(4):258-61. PubMed ID: 6442625
[TBL] [Abstract][Full Text] [Related]
17. Comparison of methods for assessing in vitro antibiotic synergism against Pseudomonas and Serratia.
Weinstein RJ; Young LS; Hewitt WL
J Lab Clin Med; 1975 Nov; 86(5):853-62. PubMed ID: 810533
[TBL] [Abstract][Full Text] [Related]
18. 'Break-point Checkerboard Plate' for screening of appropriate antibiotic combinations against multidrug-resistant Pseudomonas aeruginosa.
Tateda K; Ishii Y; Matsumoto T; Yamaguchi K
Scand J Infect Dis; 2006; 38(4):268-72. PubMed ID: 16709527
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness of antibiotic combination therapy as evaluated by the Break-point Checkerboard Plate method for multidrug-resistant Pseudomonas aeruginosa in clinical use.
Nakamura I; Yamaguchi T; Tsukimori A; Sato A; Fukushima S; Mizuno Y; Matsumoto T
J Infect Chemother; 2014 Apr; 20(4):266-9. PubMed ID: 24486172
[TBL] [Abstract][Full Text] [Related]
20. Levofloxacin/imipenem prevents the emergence of high-level resistance among Pseudomonas aeruginosa strains already lacking susceptibility to one or both drugs.
Lister PD; Wolter DJ; Wickman PA; Reisbig MD
J Antimicrob Chemother; 2006 May; 57(5):999-1003. PubMed ID: 16513915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]